On the relationship between androgen-deprivation therapy for prostate cancer and risk of infection by SARS-CoV-2

被引：28
|
作者：
Caffo, O. [1 ]
Zagonel, V. [2 ]
Baldessari, C. [3 ]
Berruti, A. [4 ]
Bortolus, R. [5 ]
Buti, S. [6 ]
Ceresoli, G. L. [7 ]
Donini, M. [8 ]
Ermacora, P. [9 ]
Fornarini, G. [10 ]
Fratino, L. [11 ]
Masini, C. [12 ]
Massari, F. [13 ]
Mosca, A. [14 ]
Mucciarini, C. [15 ]
Procopio, G. [16 ]
Tucci, M. [17 ]
Verri, E. [18 ]
Zucali, P. [19 ]
Buttigliero, C. [20 ]
机构：
[1] Santa Chiara Hosp, Dept Med Oncol, Trento, Italy
[2] Veneto Inst Oncol IOV IRCCS, Dept Oncol, Oncol 1, Padua, Italy
[3] Univ Hosp Modena, Med Oncol Unit, Modena, Italy
[4] Univ Brescia, ASST Spedali Civili, Med Oncol Unit, Brescia, Italy
[5] Ctr Riferimento Oncol Aviano CRO IRCCS, Dept Radiat Oncol, Aviano, Italy
[6] Univ Hosp Parma, Med Oncol Unit, Parma, Italy
[7] Humanitas Gavazzeni, Thorac & Urol Oncol Unit, Bergamo, Italy
[8] ASST Cremona, Dept Med Oncol, Cremona, Italy
[9] Univ Hosp Udine, Dept Oncol, Udine, Italy
[10] IRCCS Azienda Osped Univ San Martino IST Ist Nazl, Med Oncol Dept, Genoa, Italy
[11] Ctr Riferimento Oncol Aviano CRO IRCCS, Dept Med Oncol, Aviano, Italy
[12] IRCCS Reggio Emilia, Med Oncol Unit, AUSL, Reggio Emilia, Italy
[13] St Orsola Marcello Malpighi Hosp, Div Oncol, Bologna, Italy
[14] FPO IRCCS, Candiolo Canc Inst, Multidisciplinary Oncol Outpatient Clin, Candiolo, Italy
[15] Ramazzini Hosp, Dept Med Oncol, Carpi, Italy
[16] Fdn IRCCS Ist Nazl Tumori Milan, Genitourinary Oncol Unit, Milan, Italy
[17] Cardinal Massaia Hosp, Dept Med Oncol, Asti, Italy
[18] European Inst Oncol IRCCS, Med Oncol Div Urogenital & Head & Neck Tumours, IEO, Milan, Italy
[19] IRCCS, Humanitas Clin & Res Ctr, Dept Oncol, Milan, Italy
[20] Univ Torino, San Luigi Hosp, Med Oncol Dept, Orbassano, Italy
来源：
ANNALS OF ONCOLOGY | 2020年 / 31卷 / 10期
关键词：
D O I：
10.1016/j.annonc.2020.06.005
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
引用
收藏
页码：1415 / 1416
页数：2
相关论文
共 50 条
  • [1] Relationship Between Androgen Deprivation Therapy for Prostate Cancer and Risk of SARS-CoV-2 Infection: A Systematic Review and Meta-Analysis
    Kim, Do Kyung
    Park, Jae Joon
    Yang, Won Jae
    Doo, Seung Whan
    Kim, Jae Heon
    JOURNAL OF KOREAN MEDICAL SCIENCE, 2022, 37 (31)
  • [2] Androgen Deprivation Therapy in Men with Prostate Cancer Does Not Affect Risk of Infection with SARS-CoV-2
    Klein, Eric A.
    Li, Jianbo
    Milinovich, Alex
    Schold, Jesse D.
    Sharifi, Nima
    Kattan, Michael W.
    Jehi, Lara
    JOURNAL OF UROLOGY, 2021, 205 (02): : 441 - 443
  • [3] Androgen-deprivation therapies for prostate cancer and risk of infection by SARS-CoV-2: a population-based study (N=4532)
    Montopoli, M.
    Zumerle, S.
    Vettor, R.
    Rugge, M.
    Zorzi, M.
    Catapano, C., V
    Carbone, G. M.
    Cavalli, A.
    Pagano, F.
    Ragazzi, E.
    Prayer-Galetti, T.
    Alimonti, A.
    ANNALS OF ONCOLOGY, 2020, 31 (08) : 1040 - 1045
  • [4] Re: Androgen-deprivation Therapies for Prostate Cancer and Risk of Infection by SARS-CoV-2: A Population- based Study (n=4532)
    Brookman-May, Sabine D.
    May, Matthias
    EUROPEAN UROLOGY, 2020, 78 (06) : 930 - 931
  • [5] Impacts of androgen deprivation therapy on the risks and outcomes of SARS-CoV-2 infection in patients with prostate cancer
    Huang, Yuan-Bin
    Li, Wei-Lin
    Sun, Man
    Duan, Xu
    Wang, Yu-Tong
    Zhang, Lu-Xin
    Xin, Zi-Han
    Yun, Zhi-Fei
    Fan, Bo
    Li, Xian-Cheng
    ASIAN JOURNAL OF ANDROLOGY, 2023, 25 (03) : 366 - 374
  • [6] Androgen deprivation and SARS-CoV-2 in men with prostate cancer
    Koskinen, M.
    Carpen, O.
    Honkanen, V.
    Seppanen, M. R. J.
    Miettinen, P. J.
    Tuominen, J. A.
    Raivio, T.
    ANNALS OF ONCOLOGY, 2020, 31 (10) : 1417 - 1418
  • [7] Androgen-deprivation therapy and SARS-Cov-2 infection: the potential double-face role of testosterone
    Salciccia, Stefano
    Del Giudice, Francesco
    Eisenberg, Michael L.
    Mastroianni, Claudio M.
    De Berardinis, Ettore
    Ricciuti, Gian Piero
    Maggi, Martina
    Sciarra, Alessandro
    THERAPEUTIC ADVANCES IN ENDOCRINOLOGY AND METABOLISM, 2020, 11
  • [8] Susceptibility to SARS-Cov-2 infection and risk for severe COVID-19 in patients with prostate cancer on androgen deprivation therapy
    Gedeborg, Rolf
    Loeb, Stacy
    Styrke, Johan
    Kiiski-Berggren, Ritva
    Garmo, Hans
    Stattin, Par
    INTERNATIONAL JOURNAL OF CANCER, 2022, 151 (11) : 1925 - 1934
  • [9] Androgen-deprivation therapy and SARS-CoV-2 in men with prostate cancer: findings from the University of California Health System registry
    Kwon, D. H.
    Vashisht, R.
    Borno, H. T.
    Aggarwal, R. R.
    Small, E. J.
    Butte, A. J.
    Huang, F. W.
    ANNALS OF ONCOLOGY, 2021, 32 (05) : 678 - 679
  • [10] Is androgen deprivation therapy protective against SARS-CoV-2 infection and related complications in prostate cancer patients?
    Dalla Volta, Alberto
    Valcamonico, Francesca
    Zamboni, Stefania
    Ferrari, Vittorio D.
    Grisanti, Salvatore
    Simeone, Claudio
    Berruti, Alfredo
    MINERVA UROLOGICA E NEFROLOGICA, 2020, 72 (06) : 778 - 779
12345